Aspirin for primary prevention of atherothrombotic vascular events: how much "conclusive" is "conclusive?".

Francesco Brigo, Monica Storti, Piergiorgio Lochner, Frediano Tezzon, Raffaele Nardone (Last author)

Research output: Contribution to journal › Letter to the editor › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	910
Journal	AMERICAN JOURNAL OF CARDIOLOGY
Volume	112
Issue number	6
DOIs	https://doi.org/10.1016/j.amjcard.2013.07.001
Publication status	Published - 2013

Access to Document

@article{32b46043d8834f2983753c7945871710,

title = "Aspirin for primary prevention of atherothrombotic vascular events: how much {"}conclusive{"} is {"}conclusive?{"}.",

author = "Francesco Brigo and Monica Storti and Piergiorgio Lochner and Frediano Tezzon and Raffaele Nardone",

year = "2013",

doi = "10.1016/j.amjcard.2013.07.001",

language = "English",

volume = "112",

pages = "910",

journal = "AMERICAN JOURNAL OF CARDIOLOGY ",

issn = "0002-9149",

number = "6",

}

Research output: Contribution to journal › Letter to the editor › peer-review

TY - JOUR

T1 - Aspirin for primary prevention of atherothrombotic vascular events: how much "conclusive" is "conclusive?".

AU - Brigo, Francesco

AU - Storti, Monica

AU - Lochner, Piergiorgio

AU - Tezzon, Frediano

AU - Nardone, Raffaele

PY - 2013

Y1 - 2013

U2 - 10.1016/j.amjcard.2013.07.001

DO - 10.1016/j.amjcard.2013.07.001

M3 - Letter to the editor

C2 - 23992644

SN - 0002-9149

VL - 112

SP - 910

JO - AMERICAN JOURNAL OF CARDIOLOGY

JF - AMERICAN JOURNAL OF CARDIOLOGY

IS - 6

ER -